featured
Outcomes in Patients With MDS Undergoing Allo-HSCT Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors
JAMA Oncol 2022 Jan 13;[EPub Ahead of Print], GS Guru Murthy, S Kim, ZH Hu, N Estrada-Merly, MB Abid, M Aljurf, U Bacher, SM Badawy, A Beitinjaneh, C Bredeson, JY Cahn, J Cerny, MA Diaz Perez, N Farhadfar, RP Gale, S Ganguly, U Gergis, GC Hildebrandt, MR Grunwald, S Hashmi, NM Hossain, M Kalaycio, RT Kamble, MA Kharfan-Dabaja, BK Hamilton, HM Lazarus, J Liesveld, M Litzow, DI Marks, HS Murthy, S Nathan, A Nazha, T Nishihori, SS Patel, A Pawarode, D Rizzieri, B Savani, S Seo, M Solh, C Ustun, M van der Poel, LF Verdonck, R Vij, B Wirk, B Oran, R Nakamura, B Scott, W SaberFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.